Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11,984 GBX | -0.37% | -2.85% | +13.28% |
09:56am | AstraZeneca drug lowers cholesterol in phase 1 trial | AN |
09:46am | Cellectis: operations financed until 2026 | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.28% | 238B | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+7.10% | 204B | |
-5.93% | 203B | |
+4.23% | 161B | |
-1.70% | 160B | |
-2.21% | 120B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study